BioXcel Therapeutics Company
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.
Technology:
Artificial Intelligence, Biotechnology, Health Care
Industry:
AI, Drug Repurposing, End-to-end Drug Development, United States
Headquarters:
Branford, Connecticut, United States
Founded Date:
2017-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
2
Total Funding:
140000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-19
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership